bioAffinity Technologies, Inc.
BIAF
$3.81
-$0.19-4.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.94% | -74.51% | -33.80% | -16.40% | -13.89% |
| Total Depreciation and Amortization | -16.63% | -10.99% | 12.94% | 61.71% | 142.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 352.83% | 369.62% | 103.96% | 18.02% | 32.17% |
| Change in Net Operating Assets | 230.66% | 417.78% | 572.62% | 492.74% | -80.05% |
| Cash from Operations | -28.41% | -17.25% | -9.22% | 4.29% | -20.32% |
| Capital Expenditure | 23.39% | 7.76% | -30.27% | -175.70% | -243.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 23.39% | 7.76% | 96.72% | 96.01% | 96.42% |
| Total Debt Issued | -- | -133.56% | 515.67% | 492.42% | -- |
| Total Debt Repaid | -2.41% | 0.23% | -55.13% | -17.47% | -4.67% |
| Issuance of Common Stock | 110.30% | 244.96% | 262.57% | 138.84% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.42% | -141.37% | -- | -54.93% | -- |
| Cash from Financing | 161.81% | 338.43% | 332.44% | 164.08% | 1,731.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 411.40% | 284.20% | 100.02% | 72.55% | 80.02% |